NeurologyLive® Friday 5 — August 26, 2022

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive^®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Peer Exchange: Treatment Selection in Multiple Sclerosis Management

In episode 2 of the NeurologyLive^® Peer Exchange, "Multiple Sclerosis Treatments on the Horizon: BTK Inhibitors," Hesham Abboud, MD, PhD, and Benjamin Greenberg, MD, share their approaches to treatment selection and highlight the importance of individualizing treatment and patient education.

2: Mind Moments® Episode 71: Pediatric Sleep and School Start Times

Mind Moments^®, a podcast from NeurologyLive^®, brings you an exclusive interview with Chris Winter, MD, who discussed the effect of school start times on pediatric sleep, the prevalence of sleep disorders among children, and the trends occurring in sleep research.

3: NeuroVoices: Jay Alberts, PhD, on Using Virtual Reality to Expose the Prodromal Changes of Parkinson Disease

In the latest edition of our in-depth Q&A series, the Edward F. and Barbara A. Bell Endowed Chair at Cleveland Clinic discussed a new virtual reality tool that quantifies prodromal changes in activities of daily living for Parkinson disease, without incurring issues of sensory fatigue.

4: The Current State and Future Promise of Magnetoencephalography in Epilepsy and Beyond

Richard C. Burgess, MD, PhD, and Andreas V. Alexopoulos, MD, MPH, write that magnetoencephalography provides an opportunity for physicians to capture a more dynamic view of brain function over time and space that may offer an advantage to clinical care.

5: Long- and Short-Term Consequences of Pediatric Sleep Disorders: Jodi A. Mindell, PhD

The associate director of the Sleep Center at Children’s Hospital of Philadelphia and chair of the advisory board of the Pediatric Sleep Council discussed the detrimental effects poor sleep can have on children, both neurologically and on quality of life.

—————————————————